Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia

Blood

Volumn 113, Issue 9, 2009, Pages 1892-1898

  Yang, Hui ^a   Kadia, Tapan ^a   Xiao, Lianchun ^a   Bueso Ramos, Carlos E ^a   Hoshino, Koyu ^a   Thomas, Deborah Ann ^a   O'Brien, Susan ^a   Jabbour, Elias ^a   Pierce, Sherry ^a   Rosner, Gary L ^a   Kantarjian, Hagop M ^a   Garcia Manero, Guillermo ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; PROTEIN P15; PROTEIN P73;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; DISEASE DURATION; DISEASE FREE SURVIVAL; DNA METHYLATION; EPIGENETICS; FEMALE; GENE MUTATION; HAZARD ASSESSMENT; HUMAN; HUMAN TISSUE; HYPOTHESIS; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 61849117834     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-141002     Document Type: Article

References (21)

1. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535-1548.
2. Thomas DA, Faderl S, Cortes J, et al. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood. 2004;103:4396-4407.
3. Hoelzer DF. Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 1993;7:139-160.
4. Garcia-Manero G, Kantarjian HM. The hyper-CVAD regimen in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am. 2000;14: 1381-1396.
5. Garcia-Manero G, Thomas DA. Salvage therapy for refractory or relapsed acute lymphocytic leukemia. Hematol Oncol Clin North Am. 2001;15:163-205.
6. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet. 2000;1:11-19.
7. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415-428.
8. Garcia-Manero G, Daniel J, Smith TL, et al. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin Cancer Res. 2002;8:2217-2224.
9. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood. 2004;104:2492-2498.
10. Canalli AA, Yang H, Jeha S, et al. Aberrant DNA methylation of a cell cycle regulatory pathway composed of p73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia. Leuk Res. 2005;29:881-885.
11. Gutierrez MI, Siraj AK, Bhargava M, et al. Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup. Leukemia. 2003;17:1845-1850.
12. Shen L, Toyota M, Kondo Y, et al. Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. Blood. 2003;101:4131-4136.
13. Bueso-Ramos C, Xu Y, McDonnell TJ, et al. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status. J Clin Oncol. 2005;23:3932-3939.
14. Garcia-Manero G, Bueso-Ramos C, Daniel J, Williamson J, Kantarjian HM, Issa JP. DNA methylation patterns at relapse in adult acute lymphocytic leukemia. Clin Cancer Res. 2002;8:1897-1903.
15. Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000;18:547-561.
16. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL. GenBank. Nucleic Acids Res. 2008;36:D25-30.
17. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 1997;25:2532-2534.
18. Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B, et al. Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia. Blood. 2006;108:3271-3279.
19. Giles F, Cortes J, Garcia-Manero G, et al. Phase II study of pegylated intron in patients with essential thrombocythemia. Blood. 2001;98:629a.
20. Agrawal S, Unterberg M, Koschmieder S, et al. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res. 2007;67: 1370-1377.
21. Yang H, Thomas DA, Rytting ME, et al. Phase I study of frequent low-dose administration of decitabine, alone or in combination with hyperC-VAD, in relapsed or refractory acute lymphocytic leukemia (ALL) [Meeting Abstract]. J Clin Oncol. 2007;25:7072.